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Abstract
Imprinted genes exhibit a parent-of-origin specific pattern of expression. Such genes have been
shown to be targets of molecular defects in particular genetic syndromes such as Beckwith-
Wiedemann and Angelman syndromes. Recent reports have raised concern about the possibility
that assisted reproduction techniques, such as in vitro fertilization or intracytoplasmic sperm
injection, might cause genomic imprinting disorders. The number of reported cases of those
disorders is still too small to draw firm conclusions and the safety of these widely used assisted
reproduction techniques needs to be further evaluated.
Introduction
The first in vitro fertilization (IVF) baby was born in 1978
and intracytoplasmic sperm injection (ICSI) was intro-
duced in 1992 for the treatment of male infertility. Both
these techniques have been continually amended and
access to them improved for infertile couples. Indeed,
assisted reproduction now accounts for 1% to 3% of
births in developed countries [1]. Until recently, these
techniques were considered accurate substitutes for natu-
ral oocyte fertilization, and were therefore regarded as
safe. However, reports of children conceived by assisted
reproduction techniques (ART), and presenting with con-
genital anomalies have been published over the last 3
years. Even though the number of reported cases indicat-
ing a link between ART and congenital anomalies is still
small, the safety of these techniques needs to be evalu-
ated. In particular, the relationship between ART and the
occurrence of imprinting defects needs to be clarified.
Epigenetics and DNA methylation
Epigenetic modifications are reversible changes of the
DNA methylation pattern and chromatin structure that
can affect gene expression. In many instances, epigenetic
changes governing gene expression can be passed from
cell to cell or from parent to offspring. Epigenetic modifi-
cations themselves might therefore explain how environ-
mental factors modulate gene expression without
affecting the genetic code. The most researched epigenetic
phenomenon is DNA methylation [2].
DNA methylation is a covalent modification in which
methyl groups are added to cytosine bases located 5' of
guanosines (within cytosine-phospho-guanine (CpG)
dinucleotides sequences). Methylation is catalyzed by the
DNA cytosine-5-methyltransferase (DNA-MTase) enzyme
family. Methylation induces changes in chromatin struc-
ture and is generally associated with silencing of gene
expression, thus providing a way to control gene expres-
sion [3]. Indeed, methylation patterns are the result of
complex interactions between de novo methylation, the
maintenance of existing methylation and demethylation
[4].
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Imprinting
Genomic imprinting is an epigenetic phenomenon by
which the expression of a gene is determined by its paren-
tal origin. Only one allele of an imprinted gene is
expressed. Imprinting is controlled by DNA methylation
in such a way that a difference in methylation between the
maternal and paternal alleles correlates with the different
expression of the two parental alleles.
It is estimated that the total number of imprinted genes in
the human and mouse genomes ranges between 100 and
200 [5]. Imprinted genes are more often grouped into
clusters than scattered throughout the genome and this
organization most likely reflects a coordinated way of
gene regulation in a chromosomal region [6]. Two fea-
tures are characteristic, although not specific, to imprinted
genes. The first one is the unusual richness in CpG islands
onto which imprinted patterns of methylation are placed,
and the second one is the presence of clustered direct
repeats near or within the CpG islands [7].
Imprinting in development
In order to ensure that every generation receives the
appropriate sex-specific imprint, the genome undergoes
reprogramming. Epigenetic reprogramming has been
shown to occur during gametogenesis and during preim-
plantation development [6]. During the development of
primordial germ cells (PGC), imprinted methylation pat-
terns are removed by a mechanism of erasure [8]. Both,
passive and active demethylation may occur, although no
active demethylating enzymes have yet been identified.
The timing of erasure in PGCs is thought to be crucial.
Studies in mice showed that erasure occurred when pri-
mordial germ cells enter into the gonads [8,9]. Erasure is
followed by the establishment of sex-specific patterns of
methylation during gametogenesis. Imprint establish-
ment during gametogenesis occurs at different times in
the male and female germ lines. In males it is completed
by the haploid (meiotic) phase of spermatogenesis
whereas in females imprint acquisition occurs in oocytes
around the time of completion of the first meiotic divi-
sion [5]. Furthermore, it seems that at least in oocytes,
methylation might be acquired at different times (asyn-
chronous) for different genes [5]. Epigenetic reprogram-
ming is important for accurate development, as it controls
expression of early embryonic genes, cell cleavage and cell
determination in the early embryo [10].
Further genome reprogramming occurs during the preim-
plantation embryonic stage with epigenetic changes tak-
ing place through demethylation in non-imprinted genes
in maternal and paternal genomes. This is followed by a
genome-wide methylation at the time of implantation.
The different stages of imprint establishment, mainte-
nance and manipulations possibly disturbing them are
illustrated in Figure 1. Genomic imprinting defects might
indeed occur at any stage of the reprogramming process,
such as during imprinting erasure, acquisition or
maintenance.
The main consequence of the sex-specific establishment
and maintenance of imprinted methylation patterns is the
creation of maternal- and paternal-allele methylation dif-
ferences (differentially methylated domains or DMDs) in
or around imprinted genes. A primary DMD is established
during gametogenesis and secondary DMDs develop dur-
ing embryogenesis, most likely due to a direct influence of
a nearby primary DMD [11].
Imprinted genes are implicated in the regulation of
embryonic and fetal growth, as well as many aspects of
placental function, including placental growth and the
activity of transplacental transport systems [12]. Indeed,
in ruminants, such as sheep and cattle, a particular over-
growth syndrome known as "large offspring syndrome"
(LOS) was reported after in vitro culture of embryos. LOS
is caused by abnormal methylation of the IGF2R  gene
[13]. Imprinted genes are also involved in postnatal
behavior development. Based on the functions of
imprinted genes, disruption of normal imprinting can
have predictable consequences such as embryonic death,
excessive, defective or impaired fetal growth.
Imprinting defect syndromes in human
Several human syndromes are known to be associated
with defects in gene imprinting, including Prader-Willi,
Angelman, Beckwith-Wiedemann, Silver-Russell and
Albright hereditary oseodystrophy syndromes [1]. Aber-
rant imprinting might also play a role in cancers and
neuro-behavioral disorders such as autism.
The Beckwith-Wiedemann syndrome (BWS), whose fre-
quency in the general population is about 1/14,000, is
characterized by somatic overgrowth, congenital malfor-
mations and a predisposition to embryonic neoplasia.
The majority of cases occur sporadically. In up to 60% of
sporadic cases, the epigenetic changes occur at differen-
tially methylated regions within 11p15.5 in a region of
approximately 1 Mb. This region contains an imprinted
cluster of at least 12 genes, including the paternally
expressed genes IGF2 and KCNQ1OT1, and the mater-
nally expressed genes H19, CDKN1C and KCNQ1 [14].
Approximately 25 to 50% of BWS patients have biallelic
expression of the IGF2  gene, and some of these cases
exhibit loss of imprinting (LOI) of IGF2 which is depend-
ent on hypermethylation changes of H19 [14]. Approxi-
mately 50% of sporadic BWS have a loss of methylation
associated to a LOI at KCNQ1OT1, an untranslated RNA
within the KCNQ1 gene [15]. Some BWS cases exhibit LOI
for KCNQ1OT1 as well as LOI for IGF2 [14]. It has beenReproductive Health 2004, 1:6 http://www.reproductive-health-journal.com/content/1/1/6
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shown in BWS patients that aberrant methylation of
KCNQ1OT1  is specifically associated with overgrowth
and congenital defects, whereas aberrant methylation of
H19 is specifically associated with an increased risk of
developing tumors [16].
The Prader-Willi and Angelman syndromes (PWS/AS) are
typical examples of imprinting dysregulations leading to
severe neuro-behavioral disturbances. Their frequencies
in the general population are approximately 1/10,000 and
1/15,000, respectively. The domain involved in these two
pathologies is a 2 Mb domain on the 15q11–13 chromo-
somal region, including genes as SNRPN,  UBE3A,
ZNF127, IPW and NDN. The small percentage of AS cases
(<5%) associated with methylation defect involves loss of
methylation within the SNRPN  imprinting center (IC)
and defective expression or silencing of maternally
expressed genes within this region. However, the methyl-
ation defect associated with PWS involves methylation
within the SNRPN IC and a defective expression or silenc-
ing of paternally expressed genes within the same region.
The IC comprises 2 regulatory regions: the PWS-shortest
region of overlap (SRO) and the AS-SRO [17]. PWS-SRO
and AS-SRO seem to operate in a stepwise way to establish
imprinting during the early developmental stages [18].
Indeed, imprinting at the AS-SRO might cause maternal
allele-specific repression of the PWS-SRO, preventing acti-
vation of the corresponding genes [17].
ART and possible imprinting defects Figure 1
ART and possible imprinting defects. Possible interactions between different steps of assisted reproduction procedures 
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In addition, imprinting may have a wider impact on neu-
rological development and behavior. Some reports sug-
gest parent-specific imprinting defect in common neuro-
behavioral disorders. Autism, bipolar affective disorder,
schizophrenia [19] and other complex neuro-behavioral
phenotypes such as alcohol abuse and audiogenic seizures
[20] may be linked to imprinting disturbances. The trans-
mission of abnormalities has been shown to be depend-
ent upon which parent transmits the disease
susceptibility. Such parent-of-origin effects on disease
manifestation may be explained by a number of genetic
mechanisms, one of them being genomic imprinting [21].
For instance, a lower age of onset of symptoms following
paternal inheritance of one subtype of schizophrenia and
following maternal inheritance of Tourette's syndrome
suggests that imprinted genes are involved in the patho-
physiology of these syndromes. Similarly, parent-specific
components for late-onset Alzheimer's disease (paternal-
specific component) or familial neural tube defects
(maternal-specific component) have been described [20].
Cases of defective imprinting in ART conceptions
Prior to the establishment of sex-specific imprints in male
and female germ cell lineages, imprints are erased. After
erasure of the pre-existing imprints, the timing of acquisi-
tion of imprints is significantly different between the two
germ lines [6]. In the female germ line, methylation
occurs in the postnatal growth phase while oocytes are
arrested at the diplotene stage of prophase I [22], whereas
during spermatogenesis, methylation takes place before
meiosis [23]. Maternal imprints are continually estab-
lished as oocytes mature in females, and paternal imprints
are established as long as spermatogonia proliferate in
males. Thus, paternal imprints seem to be established ear-
lier than maternal ones. It has been shown that this sex-
specific methylation is intrinsic and cell-autonomous,
and is not due to any influence of the genital ridge somatic
cells, or gonadal environment on the primordial germ
cells [24]. Imprinting defects in the course of assisted
reproduction could theoretically occur during several
stages of the methylation erasure/re-methylation process
in male and female germ cells as well as during the early
stages of in vitro embryonic development.
The first baby conceived by IVF was born 26 years ago.
Intracytoplasmic sperm injection (ICSI), developed
approximately 10 years ago, was seen to be the reproduc-
tive solution for severe male infertility. Several studies
have established the general safety of both IVF and ICSI
[25]. Nevertheless, it was recently reported that IVF and
ICSI may be associated with an increased risk of major
birth defects. Schieve et al. [26] studied 42 463 infants
conceived with assisted reproductive techniques and
reported a higher occurrence of low (less-than-or-equal
2500 g) and very low (less-than 1500 g) birth weight in
this group compared to the control population of chil-
dren naturally conceived. Hansen et al. [27] in a study on
837 infants conceived by IVF and 301 infants conceived
by ICSI, reported rates of major birth defects (muscu-
loskeletal, cardiovascular, urogenital, gastrointestinal,
central nervous system, metabolic and poorly defined
ones), as high as 9.0% for IVF and 8.6% for ICSI concep-
tions, compared to 4.2% reported for natural conceptions.
A possible link with imprinting disturbances was not con-
sidered by the authors. These results were in part due to
the increase in multiple pregnancies, known to be associ-
ated with ART, but also due to a higher rate of low birth
weight babies among singleton pregnancies. In addition
to these associated defects, a higher incidence of sex-chro-
mosome aneuploidy has also been reported in ART con-
ceptions [27].
DeBaun et al. [28] recently reported 7 cases of BWS con-
ceived by ART, 6 of those showing an imprinting defect at
KCNQ1OT1 or H19. By comparing this rate of ART-con-
ceived BWS to the rate of ART in the general population
during the same time period, sporadic cases of BWS were
approximately six times more likely to have been con-
ceived by ART than by natural conception. The authors
suggested that causative factors may include the in-vitro
culture conditions or the exposure of the gametes or
embryos to specific media or growth factors.
Maher et al. reviewed a different set of sporadic BWS cases
and looked for an association with ART [29]. Six out of the
149 BWS cases examined were conceived by ART, and 2 of
these had a KCNQ1OT1 loss of imprinting as the causative
molecular defect. Indeed, when compared to the inci-
dence in the general population, ART had a four-fold
greater likelihood of being associated with BWS than nat-
ural conception. The cases reported by DeBaun et al. [28]
and Maher et al. [29] were recruited through registries of
BWS patients. However, parents with BWS babies born
after ART may be more likely to join BWS registries, which
could introduce bias when using these registries.
Recently, a case-control study analyzed the frequency of
BWS in 1'316'500 live births and 14'894 babies born after
an IVF procedure [30]. The risk of BWS was reported to be
9 times higher in the IVF population compared to the gen-
eral population.
Cox et al. [32] and Orstavik et al. [33] reported a total of
3 children with Angelman syndrome conceived by ICSI.
In all 3 cases, AS was due to loss of imprinting within
SNRPN gene at 15q11–13. Considering that the occur-
rence of AS in the general population is about 1/15,000
and that <5% of cases are due to epigenetic imprinting
defects, these reports suggest that the predominant abnor-
malities seen in ART are epigenetic rather than genetic.Reproductive Health 2004, 1:6 http://www.reproductive-health-journal.com/content/1/1/6
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However, no evidence of abnormal methylation patterns
at 15q11–13, the locus linked to the pathogenesis of AS
and PWS, was found in 92 children conceived by ICSI
[31].
Why might ART be harmful for the imprints
For assisted reproduction by intracytoplasmic sperm
injection (ICSI), the injection of a spermatozoon into the
ovum by micro-manipulation bypasses several of the
steps involved in fertilization. However, in male germ
cells, it seems that the paternal imprints are well estab-
lished in the mature, meiotic stages of spermatogenesis.
Furthermore, round spermatid microinjections have con-
firmed that paternal imprints are completely established
in primary spermatocytes [34]. This point is relevant to
the recent use of ICSI using round spermatids. Manning et
al. [35] have analyzed the methylation pattern in imma-
ture testicular sperm cells at different developmental
stages at the 15q11–13 imprinted region and reported
that the ejaculated spermatozoa and elongated sperma-
tids had completed the establishment of paternal methyl-
ation imprints. However, spermatozoa used for ICSI
generally originate from men with abnormal semen
parameters that may have had adversely affected the
establishment of imprints. Moreover, immature sperma-
tozoa for ICSI can also be directly collected from the testes
of infertile males. It has been hypothesized that spermato-
zoa from men with fertility problems contain a higher
number of gametes with chromosomal abnormalities
[36]. A defect in gene imprinting can be considered as a
possible sperm abnormality. Indeed, a recent report has
analyzed the imprinting of two opposite imprinted genes
(MEST and H19) in spermatozoon DNA from normo-
zoospermic and oligozoospermic patients. The data pre-
sented suggest an association between abnormal genomic
imprinting and hypospermatogenesis [37]. Theoretically,
it is possible that freezing of mature sperm or the cryopro-
tectants used might disturb the established male imprints
in mature spermatozoa or round spermatids.
Women with a variety of fertility problems, such as ovar-
ian failure and/or hormonal disturbances, may be more
prone to produce gametes with inherent imprinting
defects because of the establishment of maternal imprints
during the final phase of oocyte growth and meiotic
maturation.
Although biologically plausible, this is purely speculative
at the moment.
In addition to the theoretical possibility that there may be
innate defects in oocytes used in ART, the in vitro treat-
ment of oocytes and embryos during ART procedures
might affect the establishment of imprints in female germ
cells. For example, superovulation or in vitro maturation
of oocytes might affect the establishment of the complete
array of normal maternal imprints. Oocytes used for
assisted reproduction usually originate from women who
undergo hormonal hyperstimulation protocol followed
by fertilization in vitro. It is not clear to date if the clinical
use of high doses of gonadotrophins might alter imprint
acquisition. Gonadotrophins might cause the premature
release of immature oocytes that have not completed the
establishment of their imprints, and establishment may
not be completed during in vitro maturation. Shi and
Haaf [38] determined the possible incidence of abnormal
methylation patterns in mice embryos from superovu-
lated compared to non-superovulated female mice. An
immunostaining method was used to assess the overall
extent of genomic cytosine methylation and reported
abnormal methylation patterns in 2-cell embryos from
superovulated females as compared to non-superovulated
ones. Kerjean et al [39] explored in mice whether mater-
nal imprinting progresses normally when oocytes are cul-
tured in vitro. The authors analyzed the DMDs of 3
imprinted genes and reported that indeed in vitro culture
affected imprint establishment and might lead to loss of
methylation at certain imprinted loci, such as IGF2R and
gain of methylation at other loci, such as H19. However,
to our knowledge, no data concerning the possible effects
of ovarian hyperstimulation on imprinting in humans is
available yet.
Potential disruption of normal imprinting could result
from the in vitro manipulation of early stage embryos. In
vitro culture with the use of slightly different culture
media led to decreased fetal viability and imprinting dis-
turbances in mice. Doherty et al. [40] first reported the dif-
ferential affects of culture media in preimplantation
mouse embryos at the H19 imprinted gene. The loss of
methylation at H19 gene was associated with culture in
Whitten's media, resulting in LOI in the imprinting con-
trol domain upstream of the start of H19 transcription.
Khosla et al. [41] examined mouse preimplantation
mouse embryos cultured in different culture media and
transferred into recipient mothers. Fetal development as
well as the expression pattern of imprinted genes, includ-
ing the IGF2 and H19 genes, was influenced by the addi-
tion of fetal calf serum (FCS) in the culture media. The
mechanism by which culture media and other gamete or
embryo handling might induce defects and lack of main-
tenance of methylation at imprinted loci is not clear. It
may be due to the facilitation of removal of methyl groups
on cytosine bases or the disturbance of the gamete devel-
opment leading to incompleteness of imprint erasure
and/or establishment [10]. Furthermore, cryopreservation
of embryos could potentially affect the cytoskeleton, chro-
matin structure and the availability of methylating and/or
demethylating enzymes during preimplantation develop-
ment. However, it is not known at present if culture ofReproductive Health 2004, 1:6 http://www.reproductive-health-journal.com/content/1/1/6
Page 6 of 7
(page number not for citation purposes)
human preimplantation embryos in different media or
over longer periods – might lead to disturbances in
genomic imprinting.
Disturbances in imprinting could affect the germline cells
of the embryo conceived by assisted reproduction and the
problems of imprinting might occur in the offspring of
the subsequent generation [10]. Follow-up of these indi-
viduals may give important information about the possi-
ble risks associated with ART.
Imprinting and placenta
A critical way of regulating intrauterine development is
through placental function and growth. Most imprinted
genes are expressed in fetal and placental tissues, and are
involved in fetal growth [12]. In general, paternally
expressed imprinted genes enhance fetal growth whereas
maternally expressed imprinted ones suppress it [6].
Among the genes expressed in the placenta, the MASH2
gene was shown to regulate the development of spongio-
trophoblast [42]. Igf2 transcripts are found specifically in
the labyrinthine trophoblast [43], and ASCL2 is a tran-
scription factor expressed in the spongiotrophoblast and
labyrinthine layers [5]. Indeed, mice with deletions of
IGF2 and ASCL2 genes showed fetal growth restriction
and death during embryonic development [43,42].
In humans, several imprinting disorders are associated
with intrauterine growth restriction (IUGR) [44]. Studies
on human placental imprinted genes and on the different
roles of the maternally and paternally expressed genes are
certainly needed to understand the placenta's role in nor-
mal embryonic and fetal development. Furthermore,
analyses of placental samples obtained after ART concep-
tions might provide answers to some important questions
about the possible links between ART and genomic
imprinting.
Conclusion
Concern has been raised about the possible increased
incidence of genetic syndromes due to imprinting defects
in children conceived by assisted reproduction. In partic-
ular, experimental reports in mice have raised the ques-
tion that some of the steps involved in these techniques,
such as ovarian hyperstimulation or certain culture media
for in vitro culture of embryos might be detrimental to the
formation of genomic imprints. In order to be able to ade-
quately counsel infertile couples enquiring about ART,
solid evidence from large, well-designed studies as well as
cautious long-term evaluation of the safety of these tech-
niques need to be available. Although the unraveling of
the mechanisms underlying genomic imprinting is only at
the beginning, there is a clear need to investigate and bet-
ter understand the regulation of this process during fecun-
dation and embryogenesis.
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